2 Study Shows Drug Halves Recurrence Rate In Patients With Early-Stage EGFR-Mutated Lung Cancer! Jan 28, 2025
3 J. Enzyme Inhib. Med. Chem. | Protac Targeting Aimp2-Dx2: a New Therapy For Lung Cancer Dec 21, 2024
4 J Thorac Oncol: Survival Differences In Lung Cancer Patients By Gender And The Impact Of Prognostic Factors On Them Aug 17, 2023
Read More Apparatus Clinical Approval For Colombotide Skb264 (Mk-2870) In Combination With Oxitinib Mar 24, 2025
